The Prone Breast Radiation Therapy Trial

NACompletedINTERVENTIONAL
Enrollment

378

Participants

Timeline

Start Date

May 4, 2013

Primary Completion Date

April 30, 2018

Study Completion Date

June 30, 2019

Conditions
Ductal Carcinoma In SituInvasive Breast Cancer
Interventions
RADIATION

Radiation Therapy Positioning Intervention

All participants will receive an adjuvant XRT dose to the breast of 50Gy in 25 fractions using an IMRT technique. In both arms, boost to the surgical bed using a mini-tangent technique will be delivered at the treating oncologist's discretion. Acceptable boost doses are 1600cGy/8 fractions, 1000cGy/5 fractions or 1325cGy/25 fractions as a simulatenous integrated boost. Participants randomized to the supine arm will be positioned supine on an angled breast board, with the ipsilateral arm abducted over her head. Participants randomized to the prone arm will be positioned prone on a prone breast board with both arms immobilized above the participant's head. The us of a cushion-like VaclocTM device is permitted at the treating physician's discretion. Radiation beams will be shaped to encompass the breast volume requiring treatment in both arms.

Trial Locations (2)

V8R6V5

British Columbia Cancer Agency - Vancouver Island centre, Victoria

M4N 3M5

Sunnybrook Odette Cancer Centre, Toronto

All Listed Sponsors
collaborator

Canadian Breast Cancer Foundation

OTHER

lead

Toronto Sunnybrook Regional Cancer Centre

OTHER

NCT01815476 - The Prone Breast Radiation Therapy Trial | Biotech Hunter | Biotech Hunter